Given the importance of Th17 cells in the pathogenesis of RA, further investigations should be performed to elucidate the mechanisms underlying the inconsistent effect of anti-IL-17 therapy in RA patients. The gene discussed is IL17A; the disease is rheumatoid arthritis.